BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 26459575)

  • 21. Androgen receptor versus erbB-1 and erbB-2 expression in human prostate neoplasms.
    Brys M; Stawinska M; Foksinski M; Barecki A; Zydek C; Miekos E; Krajewska WM
    Oncol Rep; 2004 Jan; 11(1):219-24. PubMed ID: 14654929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Negative modulation of androgen receptor transcriptional activity by Daxx.
    Lin DY; Fang HI; Ma AH; Huang YS; Pu YS; Jenster G; Kung HJ; Shih HM
    Mol Cell Biol; 2004 Dec; 24(24):10529-41. PubMed ID: 15572661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retinoblastoma, a tumor suppressor, is a coactivator for the androgen receptor in human prostate cancer DU145 cells.
    Yeh S; Miyamoto H; Nishimura K; Kang H; Ludlow J; Hsiao P; Wang C; Su C; Chang C
    Biochem Biophys Res Commun; 1998 Jul; 248(2):361-7. PubMed ID: 9675141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The zinc finger protein ras-responsive element binding protein-1 is a coregulator of the androgen receptor: implications for the role of the Ras pathway in enhancing androgenic signaling in prostate cancer.
    Mukhopadhyay NK; Cinar B; Mukhopadhyay L; Lutchman M; Ferdinand AS; Kim J; Chung LW; Adam RM; Ray SK; Leiter AB; Richie JP; Liu BC; Freeman MR
    Mol Endocrinol; 2007 Sep; 21(9):2056-70. PubMed ID: 17550981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MDC1 functionally identified as an androgen receptor co-activator participates in suppression of prostate cancer.
    Wang C; Sun H; Zou R; Zhou T; Wang S; Sun S; Tong C; Luo H; Li Y; Li Z; Wang E; Chen Y; Cao L; Li F; Zhao Y
    Nucleic Acids Res; 2015 May; 43(10):4893-908. PubMed ID: 25934801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
    Zaia A; Fraizer GC; Piantanelli L; Saunders GF
    Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LMO2 upregulation due to AR deactivation in cancer-associated fibroblasts induces non-cell-autonomous growth of prostate cancer after androgen deprivation.
    Chen L; Wang YY; Li D; Wang C; Wang SY; Shao SH; Zhu ZY; Zhao J; Zhang Y; Ruan Y; Han BM; Xia SJ; Jiang CY; Zhao FJ
    Cancer Lett; 2021 Apr; 503():138-150. PubMed ID: 33503448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Androgen receptor overexpression in prostate cancer linked to Pur alpha loss from a novel repressor complex.
    Wang LG; Johnson EM; Kinoshita Y; Babb JS; Buckley MT; Liebes LF; Melamed J; Liu XM; Kurek R; Ossowski L; Ferrari AC
    Cancer Res; 2008 Apr; 68(8):2678-88. PubMed ID: 18413735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Slug, a unique androgen-regulated transcription factor, coordinates androgen receptor to facilitate castration resistance in prostate cancer.
    Wu K; Gore C; Yang L; Fazli L; Gleave M; Pong RC; Xiao G; Zhang L; Yun EJ; Tseng SF; Kapur P; He D; Hsieh JT
    Mol Endocrinol; 2012 Sep; 26(9):1496-507. PubMed ID: 22745193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of Tip60, an androgen receptor coactivator, and its role in prostate cancer development.
    Halkidou K; Gnanapragasam VJ; Mehta PB; Logan IR; Brady ME; Cook S; Leung HY; Neal DE; Robson CN
    Oncogene; 2003 Apr; 22(16):2466-77. PubMed ID: 12717424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nfib Regulates Transcriptional Networks That Control the Development of Prostatic Hyperplasia.
    Grabowska MM; Kelly SM; Reese AL; Cates JM; Case TC; Zhang J; DeGraff DJ; Strand DW; Miller NL; Clark PE; Hayward SW; Gronostajski RM; Anderson PD; Matusik RJ
    Endocrinology; 2016 Mar; 157(3):1094-109. PubMed ID: 26677878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Androgen induction of the androgen receptor coactivator four and a half LIM domain protein-2: evidence for a role for serum response factor in prostate cancer.
    Heemers HV; Regan KM; Dehm SM; Tindall DJ
    Cancer Res; 2007 Nov; 67(21):10592-9. PubMed ID: 17975004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Y-box binding protein-1 promotes castration-resistant prostate cancer growth via androgen receptor expression.
    Shiota M; Takeuchi A; Song Y; Yokomizo A; Kashiwagi E; Uchiumi T; Kuroiwa K; Tatsugami K; Fujimoto N; Oda Y; Naito S
    Endocr Relat Cancer; 2011 Aug; 18(4):505-17. PubMed ID: 21652770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vav3 oncogene is overexpressed and regulates cell growth and androgen receptor activity in human prostate cancer.
    Dong Z; Liu Y; Lu S; Wang A; Lee K; Wang LH; Revelo M; Lu S
    Mol Endocrinol; 2006 Oct; 20(10):2315-25. PubMed ID: 16762975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hic-5/ARA55, a LIM domain-containing nuclear receptor coactivator expressed in prostate stromal cells.
    Heitzer MD; DeFranco DB
    Cancer Res; 2006 Jul; 66(14):7326-33. PubMed ID: 16849583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human heterochromatin protein 1 isoform HP1beta enhances androgen receptor activity and is implicated in prostate cancer growth.
    Shiota M; Song Y; Yokomizo A; Tada Y; Kuroiwa K; Eto M; Oda Y; Inokuchi J; Uchiumi T; Fujimoto N; Seki N; Naito S
    Endocr Relat Cancer; 2010 Jun; 17(2):455-67. PubMed ID: 20308360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells.
    Takayama K; Horie-Inoue K; Ikeda K; Urano T; Murakami K; Hayashizaki Y; Ouchi Y; Inoue S
    Biochem Biophys Res Commun; 2008 Sep; 374(2):388-93. PubMed ID: 18640093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor.
    Cui Z; Ren S; Lu J; Wang F; Xu W; Sun Y; Wei M; Chen J; Gao X; Xu C; Mao JH; Sun Y
    Urol Oncol; 2013 Oct; 31(7):1117-23. PubMed ID: 22264502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NRIP/DCAF6 stabilizes the androgen receptor protein by displacing DDB2 from the CUL4A-DDB1 E3 ligase complex in prostate cancer.
    Chen HH; Fan P; Chang SW; Tsao YP; Huang HP; Chen SL
    Oncotarget; 2017 Mar; 8(13):21501-21515. PubMed ID: 28212551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ELF5-Mediated AR Activation Regulates Prostate Cancer Progression.
    Li K; Guo Y; Yang X; Zhang Z; Zhang C; Xu Y
    Sci Rep; 2017 Mar; 7():42759. PubMed ID: 28287091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.